Purpose. Special considerations in the selection of medication inhaler devices for elderly patients with chronic obstructive pulmonary disease (COPD) in the ambulatory care setting are reviewed.

Eligible patients had COPD, were ages 40 or older, and were new initiators of these inhalers from 2021 to 2023. They were ...

Budesonide-glycopyrrolate-formoterol does not improve clinical outcomes compared with fluticasone-umeclidinium-vilanterol.

Those key challenges impacting the care of respiratory diseases include delays in diagnosis due to the intermittent nature of ...

Teva has launched new digital inhaler and drug combination in the US, containing built-in sensors that connect to a phone to help manage asthma and COPD symptoms. Israel-based Teva said the ...

Discover the top 19 most notable drugs approved by the FDA in 2024, including Dupixent for COPD and FluMist for self-administration. See the full list here.

Objective: To review the basis for the estimated comparative daily dosages of inhaled corticosteroids for children and adults that are presented in the National Heart, Lung, and Blood Institute's ...

The odds are high you’ve had a cough before in your life, but each time can throw you for a loop. Even though you’ve been ...

Seek expert support for respiratory issues from pulmonologists. Learn how they diagnose and manage lung diseases for better ...

China is currently facing a surge in Covid-like human metapneumovirus (hMPV) cases, raising concerns across the country. Know ...